CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 300,600 shares at an average $0.13 ($38,777)
- 8-K Event Executive or director change
- 4 Open-market buy 10% owner bought 21,200 shares at $0.22 ($4,664)
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 269,500 shares at $0.22 ($59,290)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 1,544,145 shares at an average $0.25 ($384,712)
- 4/A Other disposition Director disposed of 3,055 shares (other)
- 4 Open-market buy 10% owner bought 641,800 shares at an average $0.23 ($148,977)
- 4 Insider Changes in Ownership
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 57 of 77 · 1,525 filings